Document Type : Mini Review
School of Medicine, University of Galway, Galway, Ireland
School of Medicine and Medical Science, University College Dublin, Dublin, Ireland
Department of Neurology, University Hospital Galway, Galway, Ireland
Parkinson disease is a progressive neurodegenerative disorder affecting the dopaminergic neurons of the basal ganglia, affecting approximately 1% of individuals over the age of 65. The travel health challenges of patients with Parkinson disease have not been adequately addressed in the medical literature. This perspective article discusses the barriers to healthy travel in this vulnerable population and considers mitigating measures. It focuses on difficulties with mobility, cognitive impairment, chronic medications, and medical devices.